AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 67 filers reported holding AUTOLUS THERAPEUTICS PLC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,187,500 | -11.2% | 625,000 | 0.0% | 0.00% | – |
| Q3 2022 | $1,338,000 | -24.4% | 625,000 | 0.0% | 0.00% | – |
| Q2 2022 | $1,769,000 | -60.0% | 625,000 | -41.1% | 0.00% | -100.0% |
| Q1 2022 | $4,423,000 | -71.2% | 1,060,579 | -64.1% | 0.00% | -50.0% |
| Q4 2021 | $15,341,000 | -20.8% | 2,955,806 | 0.0% | 0.00% | -33.3% |
| Q3 2021 | $19,361,000 | -1.4% | 2,955,806 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $19,627,000 | +15.9% | 2,955,806 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $16,937,000 | -35.9% | 2,955,806 | 0.0% | 0.00% | -40.0% |
| Q4 2020 | $26,425,000 | -23.2% | 2,955,806 | 0.0% | 0.01% | -37.5% |
| Q3 2020 | $34,406,000 | -27.4% | 2,955,806 | 0.0% | 0.01% | -27.3% |
| Q2 2020 | $47,382,000 | +167.6% | 2,955,806 | 0.0% | 0.01% | +120.0% |
| Q1 2020 | $17,705,000 | -38.9% | 2,955,806 | +34.6% | 0.01% | -16.7% |
| Q4 2019 | $28,985,000 | +37.1% | 2,195,806 | +29.0% | 0.01% | +20.0% |
| Q3 2019 | $21,149,000 | -21.5% | 1,702,830 | +1.7% | 0.01% | -16.7% |
| Q2 2019 | $26,950,000 | +40.1% | 1,673,889 | +173.9% | 0.01% | +20.0% |
| Q1 2019 | $19,232,000 | -4.2% | 611,112 | 0.0% | 0.01% | 0.0% |
| Q4 2018 | $20,069,000 | +8.9% | 611,112 | 0.0% | 0.01% | +25.0% |
| Q3 2018 | $18,431,000 | -37.5% | 611,112 | -44.4% | 0.00% | -33.3% |
| Q2 2018 | $29,469,000 | – | 1,100,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 21,346,829 | $49,738,112 | 74.10% |
| TFG Asset Management GP Ltd | 12,000,000 | $27,960,000 | 5.10% |
| Paradigm Biocapital Advisors LP | 14,406,782 | $33,567,802 | 2.28% |
| Lynx1 Capital Management LP | 1,363,025 | $3,175,848 | 2.10% |
| Deep Track Capital, LP | 15,000,000 | $34,950,000 | 1.35% |
| Affinity Asset Advisors, LLC | 1,992,466 | $4,642,446 | 1.31% |
| DAFNA Capital Management LLC | 928,253 | $2,162,829 | 0.67% |
| Frazier Life Sciences Management, L.P. | 3,746,857 | $8,730,177 | 0.58% |
| ARMISTICE CAPITAL, LLC | 6,900,000 | $16,077,000 | 0.25% |
| Blackstone Inc. | 20,485,611 | $47,731,474 | 0.20% |